Clarius Group LLC’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$3.45M Sell
16,654
-1,768
-10% -$350K 0.2% 51
2025
Q3
$3.42M Sell
18,422
-6,436
-26% -$1.1M 0.2% 51
2025
Q2
$3.8M Buy
24,858
+630
+3% +$96.8K 0.22% 51
2025
Q1
$4.02M Buy
24,228
+3,232
+15% +$506K 0.25% 50
2024
Q4
$3.04M Buy
20,996
+669
+3% +$104K 0.21% 53
2024
Q3
$3.27M Sell
20,327
-474
-2% -$75.5K 0.23% 50
2024
Q2
$3.04M Sell
20,801
-765
-4% -$114K 0.22% 49
2024
Q1
$3.41M Sell
21,566
-5,459
-20% -$869K 0.24% 48
2023
Q4
$4.24M Buy
27,025
+2,870
+12% +$440K 0.35% 40
2023
Q3
$3.76M Sell
24,155
-7,240
-23% -$1.19M 0.36% 38
2023
Q2
$5.2M Buy
31,395
+2,303
+8% +$372K 0.4% 35
2023
Q1
$4.51M Sell
29,092
-3,407
-10% -$550K 0.38% 36
2022
Q4
$5.74M Sell
32,499
-90
-0.3% -$15.5K 0.52% 28
2022
Q3
$5.32M Buy
32,589
+2,006
+7% +$339K 0.53% 27
2022
Q2
$5.43M Buy
30,583
+1,620
+6% +$289K 0.54% 26
2022
Q1
$4.96M Hold
28,963
0.39% 32
2021
Q4
$4.96M Buy
28,963
+387
+1% +$63.4K 0.39% 32
2021
Q3
$4.62M Buy
28,576
+606
+2% +$103K 0.41% 28
2021
Q2
$4.61M Buy
27,970
+934
+3% +$155K 0.41% 29
2021
Q1
$4.44M Buy
27,036
+2,871
+12% +$465K 0.44% 28
2020
Q4
$3.8M Buy
24,165
+1,874
+8% +$277K 0.41% 28
2020
Q3
$3.32M Sell
22,291
-4,387
-16% -$649K 0.43% 28
2020
Q2
$3.75M Buy
26,678
+7,258
+37% +$1.06M 0.53% 24
2020
Q1
$2.55M Buy
19,420
+1,781
+10% +$253K 0.48% 27
2019
Q4
$2.59M Sell
17,639
-34
-0.2% -$4.61K 0.41% 33
2019
Q3
$2.29M Sell
17,673
-666
-4% -$87.7K 0.42% 33
2019
Q2
$2.55M Buy
18,339
+5,366
+41% +$743K 0.51% 27
2019
Q1
$1.81M Buy
12,973
+6,370
+96% +$853K 0.44% 36
2018
Q4
$852K Buy
6,603
+1,863
+39% +$260K 0.31% 40
2018
Q3
$655K Buy
+4,740
New +$630K 0.23% 48
2017
Q3
Sell
-4,527
Closed -$599K 83
2017
Q2
$599K Sell
4,527
-7
-0.2% -$893 0.25% 46
2017
Q1
$564K Sell
4,534
-22
-0.5% -$2.63K 0.23% 49
2016
Q4
$526K Sell
4,556
-231
-5% -$26.7K 0.22% 48
2016
Q3
$565K Buy
4,787
+72
+2% +$8.73K 0.26% 44
2016
Q2
$534K Buy
+4,715
New +$536K 0.28% 44
2016
Q1
Sell
-3,779
Closed -$388K 91
2015
Q4
$388K Buy
+3,779
New +$380K 0.22% 47

Other funds holding JNJ

Clarius Group LLC's JNJ Position: Q4 2025 in Review

Clarius Group LLC reduced its Johnson & Johnson (JNJ) stake by 9.6% in Q4 2025, selling an estimated $350K and leaving 16,654 shares worth $3.45M. The position accounts for 0.2% of the portfolio, ranked #51.

Clarius Group LLC first reported a position in JNJ in Q4 2015 and has held it in 36 quarters since. The position peaked at $5.74M in Q4 2022. 4,521 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Clarius Group LLC held 16,654 shares of Johnson & Johnson worth $3.45M as of Q4 2025.
  • Clarius Group LLC sold 1,768 Johnson & Johnson shares in Q4 2025, an estimated $350K.
  • Johnson & Johnson made up 0.2% of Clarius Group LLC's portfolio in Q4 2025, its #51 holding.
  • Clarius Group LLC first reported a position in Johnson & Johnson in Q4 2015 and has held it in 36 quarters since.
  • Clarius Group LLC's Johnson & Johnson position peaked at $5.74M in Q4 2022.
  • 4,521 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.